Data gathered: November 21
AI Stock Analysis - Tilray (TLRY)
Analysis generated October 7, 2024. Powered by Chat GPT.
Tilray (NASDAQ: TLRY) is a prominent global player in the cannabis industry, engaged in the research, cultivation, processing, and distribution of cannabis and cannabis-derived products. Tilray's extensive portfolio includes medical cannabis, hemp products, and recreational cannabis products across multiple markets worldwide. Being a pioneer, Tilray has managed to establish a significant presence not only in North America but also in global markets such as Europe and Latin America.
Stock Alerts - Tilray (TLRY)
 |
Tilray | November 20 Employee Rating is up by 3.3% over the last month. |
|
Tilray | November 19 Insider Alert: Merton Carl A is buying shares |
|
Tilray | November 12 Price is up by 5.7% in the last 24h. |
|
Tilray | November 11 Price is down by -5.4% in the last 24h. |
Alternative Data for Tilray
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 73 | Sign up | Sign up | Sign up |
| Sentiment | 60 | Sign up | Sign up | Sign up |
| Webpage traffic | 36,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | 39 | Sign up | Sign up | Sign up |
| Patents | 8 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 61 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 151,085 | Sign up | Sign up | Sign up |
| Twitter Followers | 34,375 | Sign up | Sign up | Sign up |
| Twitter Mentions | 97 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | 25 | Sign up | Sign up | Sign up |
| Business Outlook | 37 | Sign up | Sign up | Sign up |
| Linkedin Employees | 988 | Sign up | Sign up | Sign up |
About Tilray
Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal, and Latin America.
| Price | $1.35 |
| Target Price | Sign up |
| Volume | 12,290,000 |
| Market Cap | $1.18B |
| Year Range | $1.29 - $2.85 |
| Dividend Yield | 0% |
| Analyst Rating | 29% buy |
| Industry | Medical Cannabis |
In the news
 |
Tilray Brands Unveils 2024 Holiday Cannabis Gift GuideNovember 21 - Financial Post |
Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift GuideNovember 21 - Financial Post |
|
 |
Prediction: Tilray Brands Won't Be a Cannabis Company in 5 YearsNovember 19 - Yahoo |
 |
Beverages, Alcohol and Tobacco Stocks Q3 Recap: Benchmarking Tilray Brands (NASDAQ:TLRY)November 19 - Yahoo |
 |
Tilray Stock Hits 52-Week Low: A Buying Opportunity or a Warning Sign?November 18 - Yahoo |
 |
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation LicenseNovember 13 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 213M | 237M | 60M | -39M | -15M | 0.000 |
| Q1 '24 | 179M | 227M | 49M | -93M | -61M | -0.120 |
| Q4 '23 | 189M | 231M | 47M | -49M | -20M | -0.070 |
| Q3 '23 | 171M | 212M | 44M | -72M | -12M | -0.100 |
| Q2 '23 | 98M | 24M | 67M | -139M | -68M | -0.150 |
Insider Transactions View All
| Merton Carl A filed to buy 26,000 shares at $1.4. November 18 '24 |
| FALTISCHEK DENISE M filed to buy 293,269 shares at $2.1. January 18 '24 |
| Gendel Mitchell filed to buy 195,796 shares at $2. January 16 '24 |
| Gendel Mitchell filed to buy 188,596 shares at $1.9. January 12 '24 |
| Merton Carl A filed to buy 20,000 shares at $1.9. January 12 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Canopy GrowthCGC |
$4 6.4% | 24 |
 |
Aurora CannabisACB |
$4.37 3.1% | 22 |
 |
Sundial GrowersSNDL |
$2.04 4.1% | 39 |
 |
OrganigramOGI |
$1.53 3.4% | 35 |
 |
Cronos GroupCRON |
$2.08 3.5% | 39 |
Read more about Tilray (TLRY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Tilray?
The Market Cap of Tilray is $1.18B.
What is the current stock price of Tilray?
Currently, the price of one share of Tilray stock is $1.35.
How can I analyze the TLRY stock price chart for investment decisions?
The TLRY stock price chart above provides a comprehensive visual representation of Tilray's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Tilray shares. Our platform offers an up-to-date TLRY stock price chart, along with technical data analysis and alternative data insights.
Does TLRY offer dividends to its shareholders?
As of our latest update, Tilray (TLRY) does not offer dividends to its shareholders. Investors interested in Tilray should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Tilray?
Some of the similar stocks of Tilray are Canopy Growth, Aurora Cannabis, Sundial Growers, Organigram, and Cronos Group.
.